Fundraising Fox
Admabiologics
NASDAQ: ADMAHackensack, US · 1 known investors
Find your way into Admabiologics
Sign up to see every warm intro you have to Admabiologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Admabiologics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ADMA Biologics is a vertically integrated manufacturer that develops and commercializes plasma-derived biologic therapies for immune-compromised patients, and operates plasma collection centers. The company markets immunoglobulin products and is a publicly traded US biopharmaceutical company.
Founders & leadership
AS
Adam S. GrossmanFounder, President & CEOAdam S. Grossman is founder, president and CEO of ADMA Biologics, a publicly traded biopharmaceutical manufacturer of plasma-derived immunoglobulin therapies and operator of plasma collection facilities. He has extensive background in the biotech, medical device, and plasma protein industries.
JB
Jerrold B. GrossmanCo-founder & Vice Chairman
KK
Kaitlin KestenbergChief Operating Officer & Senior Vice President of ComplianceKaitlin Kestenberg is Chief Operating Officer and Senior Vice President of Compliance at ADMA Biologics, where she oversees regulatory compliance, quality assurance, and project management for clinical programs and manufacturing operations. Her background includes leading regulatory affairs strategy, managing FDA submissions including the ASCENIV™ BLA, and preparing the company for FDA inspections.
TK
Terry KohlerChief Financial Officer & TreasurerTerry Kohler is Chief Financial Officer and Treasurer at ADMA Biologics, a publicly traded biopharmaceutical manufacturer of plasma-derived therapies. He brings over 20 years of finance leadership experience in biopharma, specialty pharmaceuticals, and investment banking, with expertise in capital strategy, M&A, and scaling organizations from development through commercial stages.
PT
Paul Terence Kohler, Jr.Chief Financial Officer and Treasurer
BL
Brad L. TadeChief Financial Officer and TreasurerBrad L. Tade is Chief Financial Officer and Treasurer at ADMA Biologics, where he oversees global operations finance. He brings over 20 years of experience in finance roles within medical device and pharmaceutical companies, with focus on manufacturing operations, supply chain strategy, and financial planning.
Board
DG
BE
Bryant E FongBoard director
SA
EI
Eric I RichmanBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$17M disclosed across 1 of 2 rounds · 2007–2012
▶Undisclosed amountofferedFeb 2012 · 9 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedFeb 2012 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dov GoldsteinDirector
- Adam S GrossmanExecutive Officer, Director
- Eric I RichmanDirector
- Bryant E FongDirector
- Steven A ElmsDirector
- Jerrold B GrossmanDirector
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Admabiologics went on to found or lead other companies.
Related companies · 2
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Companies working in the same space as Admabiologics.
Frequently asked questions
- What does Admabiologics do?
- ADMA Biologics is a vertically integrated manufacturer that develops and commercializes plasma-derived biologic therapies for immune-compromised patients, and operates plasma collection centers. The company markets immunoglobulin products and is a publicly traded US biopharmaceutical company.
- Who founded Admabiologics?
- Admabiologics was founded by Adam S. Grossman, Jerrold B. Grossman.
- Who are Admabiologics's investors?
- Admabiologics's investors include Aisling Capital.
- How much funding has Admabiologics raised?
- Admabiologics has disclosed $17M raised across 1 of its 2 known rounds.
- Where is Admabiologics headquartered?
- Admabiologics is headquartered in Hackensack, US.